In addition, the BAX activators could be engineered as a kill switch for cellular therapies, allowing specific induction of BAX-mediated apoptosis upon abhorrent function, e.g., cytokine storm or tumor lysis syndrome from cellular therapies expressing chimeric antigen receptors. Here, BAX is linked to Tumor Lysis Syndrome.